Skip to main content

Table 1 Controlled human exposure studies in patients with ischemic heart disease and metabolic syndrome.

From: Controlled human exposures to ambient pollutant particles in susceptible populations

Study

Subject (number)

Design

Particles

Results

Routledge et al [25]

Healthy volunteers (20)

Patients with multivessel coronary disease (20)

Placebo controlled, double-blind, randomized

Filtered air

Carbon (50 μg/m3)

SO2 (200 ppb)

Carbon + SO2

Small increases in RR interval, SDNN, rMSSD LF power immediately post-carbon exposure; Decreased RR interval, SDNN, rMSSD, and PNN50 at 4 hours post-SO2 exposure

Mills et al [29]

Healthy volunteers (30)

Double-blind, randomized, crossover

Filtered air

Diesel exhaust (300 μg/m3)

Attenuated forearm blood flow increase induced by bradykinin, acetylcholine, and nitroprusside infusion at 2 and 6 hours after exposure;

Suppressed the bradykinin-induced release in plasma t-PA 6 hours after exposure

Mills et al [24]

Patients with prior myocardial infarction (20)

Double-blind, randomized, crossover

Filtered air

Diesel exhaust (300 μg/m3)

Greater increase in the exercise-induced ischemic burden and decrement of ST segment during exposure;

No effects on preexisting vasomotor dysfunction at 6 hours post-exposure;

Reduced the bradykinin-induced release of endothelial t-PA

Tornqvist et al [30]

Healthy volunteers (15)

Double-blind, randomized, crossover

Filtered air

Diesel exhaust (300 μg/m3)

Decreased endothelium-dependent vasodilatation;

No effects on endothelium-independent vasodilatation or the bradykinin-induced release of endothelial t-PA

Mills et al [31]

Age-matched healthy volunteer (12)

Patients with stable coronary artery disease (12)

Double-blind, randomized, crossover

Filtered air

Fine and ultrafine CAPS (190 μg/m3)

CAPS did not affect vasomotor or fibrinolytic function in either middle-aged healthy volunteers or patients with coronary heart disease.

Peretz et al [35]

Healthy subjects (10)

Metabolic syndrome (17)

Double-blind, randomized, crossover

Filtered air

Diesel exhaust (100 and 200 μg/m3)

Decreased brachial artery diameter, increased plasma ET-1; No differences between healthy subjects and patients with metabolic syndrome

Carlsten et al [36]

Metabolic syndrome (16)

Double-blind, randomized, crossover

Filtered air

Diesel exhaust (100 and 200 μg/m3)

Decreased vWF at 7 hours postexposure

Carlsten et al [37]

Healthy subjects (13)

Double-blind, randomized, crossover

Filtered air

Diesel exhaust (100 and 200 μg/m3)

No changes in prothrombotic endpoints